Multicenter Quantitative and Qualitative Study of the Determinants of Participation in a Cytomegalovirus Preventive Vaccine Study in France in Women Aged 18 to 40 Years Old.

Not yet recruitingOBSERVATIONAL
Enrollment

306

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

November 30, 2024

Study Completion Date

November 30, 2024

Conditions
Recruitment
Interventions
OTHER

Qualitative interview

Interview between participant and a researcher, in order to identity the determinants of participation in a clinical trial among participants in the CMVictory vaccine trial.

OTHER

Quantitative questionnaire

Anonymous online survey using a 3-part questionnaire, studying knowledge of clinical research and the determinants of participation in a preventive vaccine study in a population of young women (aged 18-40).

Trial Locations (1)

42055

Centre Hospitalier Universitaire de St Etienne, Saint-Etienne

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER

NCT06511635 - Multicenter Quantitative and Qualitative Study of the Determinants of Participation in a Cytomegalovirus Preventive Vaccine Study in France in Women Aged 18 to 40 Years Old. | Biotech Hunter | Biotech Hunter